Illumina, Inc.
ILMN- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001110803
In the last 90 days, Illumina, Inc. insiders filed 0 open-market purchases and 6 sales; 939 institutions reported holding it in 13F filings for Q2 2026, worth $27.5B in total; ARK Invest is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Illumina, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 6 filings
- 3 insiders, $436.5M in total
- Insiders trading
- 3
- Net value
- −$436.5M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Illumina, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Coletti Julie Ann | Chief Legal Officer | 18,763 | Sep 10, 2026 | 1 |
| Barnard Steven | SVP, Chief Technology Officer | 40,927 | Sep 9, 2026 | 5 |
| Meister Keith A. | Director | 770,350Indirect | Sep 4, 2026 | 10 |
| Wedel Christensen Jakob | SVP, Strategy/Corp Development | 14,023 | Aug 20, 2026 | 5 |
| Sullivan Michael C | Chief Commercial Officer | 4,503 | Aug 7, 2026 | 1 |
| Davies Scott M | Chief Legal Officer | 20,338 | Aug 3, 2026 | 10 |
| Ullem Scott B. | Director | 11,030 | Jul 2, 2026 | 5 |
| Skovronsky Daniel | Director | 1,674 | Jun 23, 2026 | 1 |
| Leckman Patricia | SVP, Chief People Officer | 21,259 | Jun 9, 2026 | 6 |
| Ericksen Scott D | VP, Chief Accounting Officer | 14,446 | Jun 1, 2026 | 5 |
| Dorsa Caroline | Director | 15,754 | May 22, 2026 | 1 |
| Richo Anna | Director | 8,527 | May 22, 2026 | 1 |
| Schiller Philip W | Director | 22,220 | May 22, 2026 | 1 |
| Siegel Susan E | Director | 16,535 | May 22, 2026 | 1 |
| King David P | Director | 2,072 | May 22, 2026 | 1 |
| Gottlieb Scott | Director | 14,795 | May 22, 2026 | 3 |
| Thaysen Jacob | Chief Executive Officer | 109,073 | Mar 9, 2026 | 4 |
| Dhingra Ankur | SVP, Chief Financial Officer | 34,264 | Mar 9, 2026 | 1 |
| Pegels Kevin Carl | Chief of Global Operations | 29,038 | Mar 9, 2026 | 4 |
| Cunningham Everett | SVP, Chief Commercial Officer | 41,942 | Jul 8, 2025 | 0 |
| Epstein Robert S | Director | 22,139 | May 23, 2025 | 0 |
| Guthart Gary S | Director | 16,430 | May 23, 2025 | 0 |
| Arnold Frances | Director | 20,907 | May 23, 2025 | 0 |
| Rollins Carissa | SVP, Chief Information Officer | 18,447 | Apr 8, 2025 | 0 |
| Dadswell Charles | SVP, General Counsel | 20,586Indirect | Sep 17, 2024 | 0 |
| Macmillan Stephen P | Director | 4,129 | May 17, 2024 | 0 |
| Goswami Joydeep | SVP, Chief Financial Officer | 24,478 | Mar 7, 2024 | 0 |
| Reeves Kathryne Gambrell | SVP, Chief Marketing Officer | 17,965 | Mar 7, 2024 | 0 |
| Hoyt Aimee L | SVP, Chief People Officer | 8,314 | Nov 9, 2023 | 0 |
| Tousi Susan H | SVP, Chief Commercial Officer | 43,743Indirect | Nov 7, 2023 | 0 |
| Aravanis Alexander | SVP, Chief Technology Officer | 12,587 | Jul 6, 2023 | 0 |
| Teno Andrew | Director | 1,532 | May 31, 2023 | 0 |
| Frank John Edward | Chief Public Affairs Officer | 9,166 | May 9, 2023 | 0 |
| deSouza Francis A | President and CEO | 120,992 | Mar 3, 2023 | 0 |
| Febbo Phillip G. | SVP Chief Medical Officer | 14,786 | Mar 3, 2023 | 0 |
| Thompson John Wendell | Director | 10,162 | May 27, 2022 | 0 |
| Torres Jose | VP, Chief Accounting Officer | 1,748 | May 9, 2022 | 0 |
| Samad Sam | SVP and CFO | 11,297 | Mar 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2021 (view filing) | Nov 8 | 1 day | Febbo Phillip G.SVP Chief Medical Officer | SSale | −1.00K | $406.83 | −$406.8K | −24.9%3.02K after | |
| Nov 4, 2021 (view filing) | Nov 2 | 2 days | Aravanis AlexanderSVP, Chief Technology Officer | SSale | −2.93K | $412.78 | −$1.21M | −38.5%4.68K after | 7 lots |
| Nov 1, 2021 (view filing) | Oct 28 | 4 days | Tousi Susan HSVP, Chief Commercial Officer | SSale | −100 | $414.35 | −$41.4K | −0.2%41.3K after | |
| Oct 28, 2021 (view filing) | Oct 26 | 2 days | Aravanis AlexanderSVP, Chief Technology Officer | SSale | −2.93K | $423.00 | −$1.24M | −27.8%7.61K after | |
| Oct 26, 2021 (view filing) | Oct 22 | 4 days | Dadswell CharlesSVP & General Counsel | SSale | −314 | $411.00 | −$129.1K | −6.3%4.66K after | |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Aravanis AlexanderSVP, Chief Technology Officer | SSale | −2.93K | $411.82 | −$1.20M | −21.7%10.5K after | 5 lots |
| Oct 14, 2021 (view filing) | Oct 12 | 2 days | Aravanis AlexanderSVP, Chief Technology Officer | SSale | −2.93K | $409.21 | −$1.20M | −17.9%13.5K after | 5 lots |
| Sep 30, 2021 (view filing) | Sep 28 | 2 days | Tousi Susan HSVP, Chief Commercial Officer | SSale | −100 | $418.04 | −$41.8K | −0.2%41.4K after | |
| Sep 23, 2021 (view filing) | Sep 22 | 1 day | Dadswell CharlesSVP & General Counsel | SSale | −314 | $436.69 | −$137.1K | −5.9%4.97K after | |
| Sep 8, 2021 (view filing) | Apr 5-Aug 4 | 156 daysLate | Hoyt Aimee LSVP, Chief People Officer | SSale | −3.37K | $432.61 | −$1.46M | −47.3%3.76K after | 6 lots |
| Sep 1, 2021 (view filing) | Aug 30 | 2 days | Tousi Susan HSVP, Chief Commercial Officer | SSale | −300 | $463.50 | −$139.1K | −0.7%41.5K after | |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Dadswell CharlesSVP & General Counsel | SSale | −314 | $489.10 | −$153.6K | −5.6%5.29K after | |
| Aug 5, 2021 (view filing) | Aug 4 | 1 day | Tousi Susan HSVP, Chief Commercial Officer | SSale | −1.00K | $500.00 | −$500.0K | −2.3%41.8K after | |
| Jul 29, 2021 (view filing) | Jul 28 | 1 day | Tousi Susan HSVP, Chief Commercial Officer | SSale | −300 | $486.41 | −$145.9K | −0.7%42.7K after | |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Dadswell CharlesSVP & General Counsel | SSale | −314 | $482.23 | −$151.4K | −5.3%5.58K after | |
| Jul 7, 2021 (view filing) | Jul 7 | Same day | Aravanis AlexanderSVP, Chief Technology Officer | SSale | −539 | $477.59 | −$257.4K | −10.3%4.68K after |